ResearcherTohoku UniversityNo recent work listed
Akihiro Yamamura
Matched on ORCID iD 0000-0002-7227-2430; OpenAlex author ID A5103019416. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 3
- NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers. Co-author DOI 10.1016/j.bbrc.2017.01.055↗
- Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2013.10.010↗
- The expression of S100A4 in human pancreatic cancer is associated with invasion. Co-author DOI 10.1097/mpa.0b013e31828804e7↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Sunamura · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Yuriko Saiki · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Michiaki Unno · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Fuyuhiko Motoi · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Akira Horii · 3 shared papers, 2013–2017 · strength 0.12
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Paper The expression of S100A4 in human pancreatic cancer is associated with invasion. DOI 10.1097/mpa.0b013e31828804e7↗
- Shinichi Fukushige · 2 shared papers, 2013–2017 · strength 0.09
- Shinichi Egawa · 2 shared papers, 2013 · strength 0.06
- Kazuhiro Morishita · 1 shared paper, 2013 · strength 0.03
- Hiroki Nagase · 1 shared paper, 2013 · strength 0.03
- Nobukazu Tsukamoto · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.